These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 16670362

  • 1. Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine.
    Ann Pharmacother; 2006 May; 40(5):1007. PubMed ID: 16670362
    [No Abstract] [Full Text] [Related]

  • 2. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, October 2005-February 2006.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2006 Apr 07; 55(13):364-6. PubMed ID: 16601664
    [Abstract] [Full Text] [Related]

  • 3. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June 2005-September 2006.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2006 Oct 20; 55(41):1120-4. PubMed ID: 17060898
    [Abstract] [Full Text] [Related]

  • 4. Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June-July 2005.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2005 Oct 14; 54(40):1023-5. PubMed ID: 16224452
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.
    Jackson LA, Baxter R, Reisinger K, Karsten A, Shah J, Bedell L, Dull PM, V59P13 Study Group.
    Clin Infect Dis; 2009 Jul 01; 49(1):e1-10. PubMed ID: 19476428
    [Abstract] [Full Text] [Related]

  • 7. Alert on meningococcal vaccine.
    FDA Consum; 2005 Jul 01; 39(6):6. PubMed ID: 16669110
    [No Abstract] [Full Text] [Related]

  • 8. Current safety issues with quadrivalent meningococcal conjugate vaccines.
    Myers TR, McNeil MM.
    Hum Vaccin Immunother; 2018 May 04; 14(5):1175-1178. PubMed ID: 28934061
    [Abstract] [Full Text] [Related]

  • 9. Risk of Guillain-Barré syndrome following serogroup C meningococcal conjugate vaccine in Quebec, Canada.
    De Wals P, Deceuninck G, Boucher RM, Ouakki M.
    Clin Infect Dis; 2008 Apr 15; 46(8):e75-7. PubMed ID: 18444843
    [Abstract] [Full Text] [Related]

  • 10. [Guillain-Barré syndrome to meningococcal conjugate vaccine: Menveo®].
    Moukafih B, Lachhab Z, Moutaouakkil Y, Fettah H, Ahizoune A, Tadlaoui Y, Bennana A, Lamsaouri J, Bousliman Y.
    Therapie; 2019 Sep 15; 74(4):495-498. PubMed ID: 30661720
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Global Advisory Committee on Vaccine Safety, 29-30 November 2006.
    Wkly Epidemiol Rec; 2007 Jan 19; 82(3):18-24. PubMed ID: 17236262
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI).
    Can Commun Dis Rep; 2009 Apr 19; 35(ACS-3):1-40. PubMed ID: 19400026
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Guillain-Barré syndrome and immunizations.
    Randall DP.
    Dis Mon; 2010 May 19; 56(5):293-8. PubMed ID: 20493307
    [No Abstract] [Full Text] [Related]

  • 18. Statement on conjugate meningococcal vaccine for serogroups A, C, Y and W135. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI).
    Can Commun Dis Rep; 2007 May 01; 33(ACS-3):1-23. PubMed ID: 17520774
    [No Abstract] [Full Text] [Related]

  • 19. Neisseria meningitidis: epidemiology, treatment and prevention in adolescents.
    Brigham KS, Sandora TJ.
    Curr Opin Pediatr; 2009 Aug 01; 21(4):437-43. PubMed ID: 19421058
    [Abstract] [Full Text] [Related]

  • 20. Erythema multiforme after meningitis vaccine: patient safety concerns with repeat immunization.
    Studdiford J, Oppenheim L, McCann E, Altshuler M.
    Pharmacotherapy; 2006 Nov 01; 26(11):1658-61. PubMed ID: 17064213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.